$4450
$3560
The extracorporeal CO2 removal devices market is projected to reach US$182.88 million by 2031 from US$112.50 million in 2024 and to register a CAGR of 7.3% during 2025–2031.
Extracorporeal CO2 Removal Devices Market Analysis
The rising prevalence of respiratory diseases, growing awareness of minimally invasive procedures, and increasing geriatric population drive market growth. Expansion into non-ICU settings will create ample opportunities for the extracorporeal CO2 removal devices market in the coming years.
Extracorporeal CO2 Removal Devices Market Overview
Extracorporeal CO? removal (ECCO?R) devices are emerging medical technologies that are progressively being used in intensive care units for patients with acute respiratory failure, particularly those with ARDS and COPD.
The ECCO?R apparatuses are systems that force oxygenated blood to be freed of carbon dioxide, enabling the ventilation settings to be lowered and thus reducing the lung damage caused by the ventilator.
The market for these products is techno-savvy and presents several innovations in membrane technologies, resulting in higher efficiency and safety. The leading market is North America, which generates ~40% of the total revenue, followed by Europe with 30%, and Asia Pacific with 20%. Asia Pacific is the fastest-growing region during the forecast period.
As for the most critical sectors, the devices are needed in hospitals and surgical centers, with hospitals being the major contributors to the market revenue in 2024.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Extracorporeal CO2 Removal Devices Market: Strategic Insights
Market Size Value in US$ 99.93 million in 2022 Market Size Value by US$ 170.54 million by 2030 Growth rate CAGR of 6.9% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Extracorporeal CO2 Removal Devices Market Drivers and Opportunities
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Extracorporeal CO2 Removal Devices Market: Strategic Insights
| Market Size Value in | US$ 99.93 million in 2022 |
| Market Size Value by | US$ 170.54 million by 2030 |
| Growth rate | CAGR of 6.9% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Drivers:
Rising Prevalence of Respiratory Diseases:
Such situations as COPD, ARDS, and COVID-19 have become more frequent in recent years. As a result, the need for advanced respiratory support technologies such as extracorporeal CO2 removal devices has also increased.Growing Awareness of Minimally Invasive Procedures:
Both patients and doctors prefer minimally invasive methods. Thus, the use of extracorporeal CO2 removal devices has been on the rise, which helps lower risks and achieve better results compared to traditional ventilation.Increasing Geriatric Population:
The elderly population is more vulnerable to respiratory diseases, which increases the demand for novel treatments such as the use of extracorporeal CO2 removal for chronic and acute respiratory failure.
Market Opportunities:
Rising Demand in Emerging Economies:
Developing countries are facing an increase in respiratory diseases. They are upgrading their healthcare systems, which in turn is generating strong demand for affordable extracorporeal CO? removal (ECCO?R) devices and broader adoption of the technology.Expansion into Non-ICU Settings:
Innovations in small and simple-to-operate ECCO?R equipment make the use of such devices possible beyond intensive care units, thus the facility's applications are growing in the departmental echelons of emergency, step-down, and specialized respiratory care units.Integration of ECCO?R with Other Therapies:
The use of ECCO?R in conjunction with mechanical ventilation or renal replacement therapy leads to improved patient outcomes, providing the opportunity for comprehensive care in cases of multi-organ failure and complicated respiratory conditions.
Extracorporeal CO2 Removal Devices Market Report Segmentation Analysis
The extracorporeal CO2 removal devices market is divided into different segments to give a clearer view of how it works, its growth potential, and the latest trends. Below is the standard segmentation approach used in most industry reports:
By Product:
Extracorporeal CO2 Devices:
The setups are sophisticated, removing carbon dioxide from the blood of those with respiratory failure. Consequently, the need for ventilators is reduced, and the lungs are not as severely damaged by ventilation in intensive care units.Consumables:
These are essential components, such as membranes, circuits, and cannulas, which are necessary for the device to function correctly. The recurring demand for them is the primary source of the company's revenue and a prerequisite for the safety and long-term continuation of the treatment.
By Application:
Chronic Obstructive Pulmonary Disease (COPD):
The setups are sophisticated, removing carbon dioxide from the blood of those with respiratory failure. Consequently, the need for ventilators is reduced, and the lungs are not as severely damaged by ventilation in intensive care units.Acute Respiratory Distress Syndrome (ARDS):
These are essential components, such as membranes, circuits, and cannulas, necessary for the device to function correctly. The recurring demand for them is the primary source of the company's revenue and a prerequisite for the safety and long-term continuation of the treatment.Others:
Leading to the inclusion of applications in asthma, cystic fibrosis, and post-operative respiratory failure, in which ECCO?R is a source of supportive therapy for stabilization and prevention of the progression of invasive ventilation.
By End User:
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Others
By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
The extracorporeal CO2 removal devices market in North America is expected to hold a significant market share. Factors such as the rising prevalence of respiratory diseases, growing awareness of minimally invasive procedures, and increasing geriatric population are likely to drive the market growth.
Market Report ScopeExtracorporeal CO2 Removal Devices Market Share Analysis by Geography
Asia Pacific is expected to grow the fastest in the next few years. Emerging markets in South and Central America, the Middle East, and Africa also offer many untapped opportunities for extracorporeal CO2 removal devices providers to expand.
The extracorporeal CO2 removal devices market grows differently in each region, owing to the recommendations of regulatory agencies and medical guidelines for extracorporeal CO2 removal devices. Below is a summary of market share and trends by region:
1. North America
Market Share:
Holds a significant portion of the global marketKey Drivers:
Region leading the way owing to an advanced health care system, high prevalence of COPD and ARDS, strong reimbursement support, and early adoption of innovative critical care technologies such as ECCO?R.Trends:
Miniaturization and Portability
2. Europe
Market Share:
Substantial share due to increasing prevalence of pain conditionsKey Drivers:
Stable healthcare systems, support for clinical research, and the increasing number of older adults contributed to the widespread use of ECCO?R, particularly in Germany, the UK, France, and other Western European countries.
Trends:
Integration with Artificial Intelligence and Machine Learning
3. Asia Pacific
Market Share:
Fastest-growing region with rising market shares every yearKey Drivers:
The market is experiencing rapid growth owing to improved healthcare access, increased burden of respiratory diseases, and heightened investments in critical care technologies in China, India, Japan, and Southeast Asia.Trends:
Innovations in ECCO?R Devices
4. South and Central America
Market Share:
Growing market with steady progressKey Drivers:
Region in transition with increasing awareness of the need for advanced respiratory care; however, still constrained by the lack of proper infrastructure and low-income levels. Government programs and private partnerships support the market expansion.
Trends:
Technological developments in respiratory devices
5. Middle East and Africa
Market Share:
Although small, but growing quicklyKey Drivers:
Slowly increasing usage of ECCO?R due to a higher healthcare budget, mainly in Gulf countries, while the majority of Africa is still struggling with problems of access and affordability.Trends:
Growth in Respiratory Products
Extracorporeal CO2 Removal Devices Market Players Density: Understanding Its Impact on Business Dynamics
High Market Density and Competition
Competition is strong due to established players such as Medtronic Plc, Fresenius Medical Care AG & Co KGaA, and Baxter International Inc. Regional and niche providers such as Aferetica s.r.l., ESTOR S.P.A. add to the competitive landscape across different regions.
This high level of competition urges companies to stand out by offering:
- Advanced products
- Value-added services such as customization and sustainable solutions
- Competitive pricing models
- Compliance with regulatory guidelines
Opportunities and Strategic Moves
- Companies are spending more on research and development, which drives innovation in detection technologies. This also improves the sensitivity and specificity, addressing specific eye health issues in different regions.
- Manufacturers will likely focus on local production to cut costs and strengthen supply chains, especially in high-volume markets such as India.
Other companies analyzed during the course of research:
- Toray Medical Co., Ltd.
- ALung?Technologies,?Inc.
- Hemovent?GmbH
- MicroPort?Scientific?Corporation
- Abiomed,?Inc.
- Braile?Biomedica
- Drägerwerk?AG?&?Co.?KGaA
Extracorporeal CO2 Removal Devices Market News and Recent Developments
Medtronic receives CE Mark for VitalFlow ECMO System, ushering in a new era of critical care in Europe
Medtronic plc announced a significant advancement in its mission to transform critical care. The VitalFlow Extracorporeal Membrane Oxygenation (ECMO) System has officially received CE (Conformité Européenne) Mark approval in Europe. This milestone signals a significant leap forward in delivering seamless, life-saving support to the most fragile patients.Fresenius Medical Care is taking the next step in extracorporeal life support with Xenios 2.0
Fresenius Medical Care’s heart & lung business unit, Xenios AG, introduces the all-new Xenios 2.0. This system enables healthcare professionals to take the next step in extracorporeal life support (ECLS). It can be used for the full range of ECLS treatments, from neonatal to adult patients, and is approved in accordance with the new Medical Device Regulation (MDR).
Extracorporeal CO2 Removal Devices Market Report Coverage and Deliverables
The "Extracorporeal CO2 removal devices Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Extracorporeal CO2 removal devices market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Extracorporeal CO2 removal devices market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Extracorporeal CO2 removal devices market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Extracorporeal CO2 removal devices market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Application, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America dominated the market in 2024.
The rising prevalence of respiratory diseases, growing awareness of minimally invasive procedures, and increasing geriatric population drive market growth.
The extracorporeal CO2 removal devices market is estimated to register a CAGR of 7.3% during the forecast period.
The extracorporeal CO2 removal devices market is estimated to reach US$182.88 million by 2031.
Medtronic Plc, Fresenius Medical Care AG & Co KGaA, Baxter International Inc, Eurosets SRL, Getinge AB, Medica S.p.A., Aferetica s.r.l., LivaNova Plc, ESTOR S.P.A., and Terumo Corp are among the key players operating in the extracorporeal CO2 removal devices market.
The List of Companies - Extracorporeal CO2 Removal Devices Market
- Medtronic Plc
- Fresenius Medical Care AG & Co KGaA
- Baxter International Inc
- Eurosets SRL
- Getinge AB
- Medica S.p.A.
- Aferetica s.r.l.
- LivaNova Plc
- ESTOR S.P.A.
- Terumo Corp
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Extracorporeal CO2 Removal Devices Market
Nov 2025
Peritoneal Dialysis Equipment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Peritoneal Dialysis Solution, Peritoneal Dialysis Catheters, Peritoneal Dialysis Transfer Sets, and Others), Dialysis Type (Continuous Ambulatory Peritoneal Dialysis (CAPD), and Automated Peritoneal Dialysis (APD)), End User (In-Center Dialysis Settings, and Home Care Settings), and Geography
Nov 2025
Urokinase API and Finished Dosage Forms Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Active Pharmaceutical Ingredient and Finished Dosage Forms), Manufacturing Process (Urine-derived, Cell Culture-based, and Recombinant Technology), Indication (Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), Catheter Occlusion, Myocardial Infarction (Heart Attack), Peripheral Arterial Occlusive Diseases, and Others), Distribution Channel (Hospital Pharmacies, Retail and Drug Stores, Direct Sales (API and FDF), and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Nov 2025
Aesthetic Fillers and Exosomes Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type [Dermal Fillers (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate (PMMA), Fat Fillers, and Others) and Exosome-Based Aesthetic Products (Human-derived, Animal-derived, and Plant-derived)], Route of Administration [Injectable, Topical (Serum, Cream, Mask, and Others)], Application (Skin Rejuvenation, Wrinkle Reduction and Fine Line Correction, Facial Contouring, Lip Augmentation, Scar and Pigmentation, Post-procedure Recovery, Hair Restoration, and Others), End User (Hospitals, Dermatology Clinics, Medical Spas, and Others), and Geography (North America, Europe, and Middle East)
Nov 2025
Veterinary Diagnostics Products Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Kits and Reagents [ELISA Test Kits, Antibodies Test Kits, Polymerase Chain Reaction (PCR) Test Kits, Hematology Test Kits, Biochemistry Test Kits, Immunoassay Reagents, and Others]and Analyzers [Biochemistry Analyzers, Hematology Analyzers, Immunoassay Analyzers, PCR Analyzers, and Others]), Animal Type (Companion Animal [Dogs, Cats, Horses, and Others] and Livestock Animal [Cattles, Pigs, Poultry, and Others]), Application (Infectious Diseases [Rabies, Avian Influenza, Leishmania, Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection, and Others] and Non-Infectious Diseases [Pneumonia, Gastritis, Bronchitis, and Others]), End User (Public Healthcare Facilities and Private Healthcare Facilities), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Nov 2025
High Potent Pharmaceuticals Product Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type [APIs (Synthetic High Potency Active Pharmaceutical Ingredients and Biotech High Potency Active Pharmaceutical Ingredients) and Finished Dosage Forms (Tablets, Capsules, Injectables, and Others)], Drug Type (Innovative Drugs and Generic Drugs), Indication (Oncology, Hormonal Disorders, Autoimmune or Immunology, Infectious Diseases, CNS Disorders, Cardiovascular Diseases, and Others), Manufacturing Type (In-House Manufacturing and Outsourced (Contract Manufacturing)), Distribution Channel (Hospital Pharmacies, Retail and Drug Stores, Online Pharmacies, and Others)
Nov 2025
Delay Condoms Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Condoms and Dental Dams), Category (Flavored and Plain), Material (Latex and Non-Latex), Distribution Channel (Supermarkets and Hypermarkets, Pharmacies and Drug Stores, Online Retails and Others), and Geography
Nov 2025
Wheelchair and Mobility Aids Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Wheelchairs (Manual, Powered, Power Assisted, and Accessories), Mobility Scooters, Walking Aids, and Others), Application (Neurologically Impaired, Handicap Patients, and Other Applications), End User (Homecare, Hospitals and Clinics, Rehabilitation Centers, and Others), and Distribution Channel (Online and Offline)
Nov 2025
Cystoscopy and Ureteroscopy Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type [Cystoscope (Rigid and Flexible), and Ureteroscope (Flexible and Semi-Flexible)], Procedure (Stone Management, Bladder Cancer, Benign Prostatic Hyperplasia, and Others), Technology (Fiberoptic and Video), Usage Type (Reusable and Single Use), End User (Hospitals, Ambulatory Surgical Centers and Specialty Clinics), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, South and Central America)